Landos Biopharma (LABP) director Garabedian received 18,000 Stock Option (right to buy)
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Christopher Nishan Garabedian (director at Landos Biopharma Inc., LABP) reported that they received 18,000 Stock Option (right to buy) on May 23, 2023.
- Reporting person
- Garabedian Christopher Nishan
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| May 23, 2023 | Grant or award (A) | Stock Option (right to buy)On 18,000 Common Stock1 | +18,000 | - | - | 18,000 direct |
Holdings before and after
- Stock Option (right to buy): 0 to 18,000 direct
Footnotes from the filing
- 1. The shares subject to this option will vest and become exercisable on May 23, 2024, subject to the Reporting Person providing continuous service through such date.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Garabedian report in this LABP Form 4?
Christopher Nishan Garabedian (director at Landos Biopharma Inc., LABP) reported that they received 18,000 Stock Option (right to buy) on May 23, 2023.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for LABP
Earlier insider filings at LABP
- May 24, 2023SEC Form 4 filed by Callori Fred
- May 24, 2023SEC Form 4 filed by Adsett Roger
- Mar 3, 2023SEC Form 4: Bassaganya-Riera Josep sold 5,720,868 shares
- Mar 2, 2023SEC Form 4 filed by Cataldi Fabio
- Mar 2, 2023SEC Form 4 filed by Oakes Gregory
Quantisnow market dataNASDAQ
LABP
Landos Biopharma Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2021
Get push alerts for LABP
Full LABP profile on Quantisnow Follow LABP and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time